BioVaxys Technology Corp. (BVAXF)
USD 0.02
(-5.22%)
USD 0.02
(-5.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.4 Million CAD | -167.12% |
| 2022 | 3.57 Million CAD | 155.77% |
| 2021 | -6.41 Million CAD | -486.69% |
| 2020 | -1.09 Million CAD | -376.29% |
| 2019 | -229.69 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -370.7 Thousand CAD | 91.16% |
| 2024 Q2 | -539.19 Thousand CAD | -45.45% |
| 2024 Q3 | -802.18 Thousand CAD | -48.78% |
| 2023 Q2 | 97.97 Thousand CAD | 111.25% |
| 2023 Q1 | -871.04 Thousand CAD | -113.0% |
| 2023 FY | -6.45 Million CAD | -280.28% |
| 2023 Q4 | -4.19 Million CAD | -1022.91% |
| 2023 Q3 | 454.33 Thousand CAD | 363.75% |
| 2022 Q4 | 6.7 Million CAD | 842.36% |
| 2022 Q3 | -902.89 Thousand CAD | 11.38% |
| 2022 FY | 3.57 Million CAD | 155.77% |
| 2022 Q2 | -1.01 Million CAD | 15.19% |
| 2022 Q1 | -1.2 Million CAD | 52.03% |
| 2021 Q4 | -2.5 Million CAD | -184.12% |
| 2021 FY | -6.41 Million CAD | -486.69% |
| 2021 Q3 | -881.41 Thousand CAD | 41.05% |
| 2021 Q2 | -1.49 Million CAD | 2.77% |
| 2021 Q1 | -1.53 Million CAD | -79.81% |
| 2020 Q3 | -139.8 Thousand CAD | -113.75% |
| 2020 Q1 | -33.6 Thousand CAD | 50.49% |
| 2020 FY | -1.09 Million CAD | -376.29% |
| 2020 Q4 | -855.19 Thousand CAD | -511.7% |
| 2020 Q2 | -65.4 Thousand CAD | -94.62% |
| 2019 Q3 | -37.8 Thousand CAD | 35.45% |
| 2019 Q1 | -65.44 Thousand CAD | 49.77% |
| 2019 FY | -229.69 Thousand CAD | 0.0% |
| 2019 Q4 | -67.88 Thousand CAD | -79.55% |
| 2019 Q2 | -58.56 Thousand CAD | 10.51% |
| 2018 Q4 | -130.28 Thousand CAD | -321.14% |
| 2018 Q3 | -30.93 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.16 Million USD | 24.167% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -157.962% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 8.56% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 86.538% |
| GB Sciences, Inc. | -1.42 Million USD | -69.137% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 29.439% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -991.705% |
| Skye Bioscience, Inc. | -13.67 Million USD | 82.427% |
| Zenith Capital Corp. | -8.94 Million USD | 73.134% |
| Agentix Corp. | -1.37 Million USD | -75.148% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 52.372% |
| Biomind Labs Inc. | -1 Million USD | -137.975% |
| ContraFect Corporation | -56.88 Million USD | 95.777% |
| CSL Limited | 3.7 Billion USD | 100.065% |
| CytoDyn Inc. | -18.05 Million USD | 86.695% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -28.869% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -516.732% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 95.672% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -478.273% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -56.414% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -249.749% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 102.935% |
| SQZ Biotechnologies Company | -75.82 Million USD | 96.831% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -20.948% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 96.653% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 15.713% |
| Mesoblast Limited | -84.14 Million USD | 97.145% |
| Marizyme, Inc. | -34.08 Million USD | 92.951% |
| Genus plc | 6.4 Million USD | 137.541% |
| Pharming Group N.V. | -4.87 Million USD | 50.762% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 71.226% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -71.371% |
| IMV Inc. | -38.67 Million USD | 93.787% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 12.659% |
| MultiCell Technologies, Inc. | -722.81 USD | -332297.449% |
| ONE Bio Corp. | 13.68 Million USD | 117.561% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 95.927% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 167.87% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 17.187% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 63.86% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -7921.508% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 84.86% |
| Alpha Cognition Inc. | -9.7 Million USD | 75.245% |
| Enzolytics Inc. | -2.14 Million USD | -11.811% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 99.435% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -130.134% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 17.703% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.422% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 148.885% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -817.984% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 2.147% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -1300.856% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -19.845% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 124.661% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 47.25% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | 35.869% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -144.154% |
| EV Biologics, Inc. | -483.06 Thousand USD | -397.369% |
| Q BioMed Inc. | -3.44 Million USD | 30.271% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -91.29% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 95.629% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 69.114% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -24.319% |
| HST Global, Inc. | -140.9 Thousand USD | -1605.098% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -79.912% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -113.582% |
| Halberd Corporation | -75.05 Thousand USD | -3101.335% |
| Resverlogix Corp. | -12.74 Million USD | 81.155% |
| Cell Source, Inc. | -4.32 Million USD | 44.453% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -52.126% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 6.69 Million USD | 135.898% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -13691.413% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -2.46 Million USD | 2.601% |
| Kadimastem Ltd | -3.04 Million USD | 20.974% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 43.314% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -1223.857% |
| LadRx Corporation | -3.82 Million USD | 37.164% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -249.749% |
| Affymax, Inc. | -15.04 Million USD | 84.032% |
| Itoco Inc. | -919.14 Thousand USD | -161.397% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -114.71% |
| Mobile Lads Corp. | -554.55 Thousand USD | -333.253% |
| International Stem Cell Corporation | -663 Thousand USD | -262.383% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | 37.107% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -9445.499% |
| Qrons Inc. | -643.67 Thousand USD | -273.262% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -325.448% |
| SYBLEU INC | -149.18 Thousand USD | -1510.539% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -7.746% |
| Rebus Holdings, Inc. | -664 Thousand USD | -261.838% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -32.279% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -4464.214% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -11712.203% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 93.375% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -48.492% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -226.514% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 22.771% |
| Neutra Corp. | -229.48 Thousand USD | -946.949% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 86.301% |
| PureTech Health plc | -146.19 Million USD | 98.357% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 88.82% |
| IXICO plc | -1.43 Million USD | -67.196% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 74.685% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 98.028% |
| CSL Limited | 3.81 Billion USD | 100.063% |
| Cellectis S.A. | -108.85 Million USD | 97.793% |